These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21915484)

  • 1. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Moreira RP; Jorge AA; Gomes LG; Kaupert LC; Massud Filho J; Mendonca BB; Bachega TA
    Clinics (Sao Paulo); 2011; 66(8):1361-6. PubMed ID: 21915484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Gomes LG; Madureira G; Mendonca BB; Bachega TA
    Clinics (Sao Paulo); 2013; 68(2):147-52. PubMed ID: 23525308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
    Zimmermann A; Sido PG; Schulze E; Al Khzouz C; Lazea C; Coldea C; Weber MM
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):477-84. PubMed ID: 19170706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sandrini R; Jospe N; Migeon CJ
    Acta Paediatr Suppl; 1993 Mar; 388():56-60; discussion 61. PubMed ID: 8329832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal nodules in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: regression after adequate hormonal control.
    Giacaglia LR; Mendonca BB; Madureira G; Melo KF; Suslik CA; Arnhold IJ; Bachega TA
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):415-9. PubMed ID: 11327375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
    Bulsari K; Falhammar H
    Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of cortisone acetate therapy in 21-hydroxylase deficiency in early infancy.
    Jinno K; Sakura N; Nomura S; Fujitaka M; Ueda K; Kihara M
    Pediatr Int; 2001 Oct; 43(5):478-82. PubMed ID: 11737708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form.
    Valentino R; Savastano S; Tommaselli AP; Scarpitta MT; Dorato M; Gigante M; Calvanese E; Carlino M; Lombardi G
    J Endocrinol Invest; 1997 Dec; 20(11):690-4. PubMed ID: 9492111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance of cortisol-cortisone interconversion is shifted towards cortisol in neonates with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kamrath C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2014 Sep; 143():386-91. PubMed ID: 24861266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
    Sellick J; Aldridge S; Thomas M; Cheetham T
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N; Di Maio S; Salerno M; Argenziano A; Franzese A; Tenore A
    Horm Res; 1997; 47(1):17-22. PubMed ID: 9010713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
    Bacila I; Freeman N; Daniel E; Sandrk M; Bryce J; Ali SR; Yavas Abali Z; Atapattu N; Bachega TA; Balsamo A; Birkebæk N; Blankenstein O; Bonfig W; Cools M; Costa EC; Darendeliler F; Einaudi S; Elsedfy HH; Finken M; Gevers E; Claahsen-van der Grinten HL; Guran T; Güven A; Hannema SE; Higham CE; Iotova V; van der Kamp HJ; Korbonits M; Krone RE; Lichiardopol C; Luczay A; Mendonca BB; Milenkovic T; Miranda MC; Mohnike K; Neumann U; Ortolano R; Poyrazoglu S; Thankamony A; Tomlinson JW; Vieites A; de Vries L; Ahmed SF; Ross RJ; Krone NP
    Eur J Endocrinol; 2021 Apr; 184(4):553-563. PubMed ID: 33460392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a clinical practice audit.
    Li HY; Dahir KM; Blevins LS
    Endocr Pract; 2003; 9(5):347-52. PubMed ID: 14583416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.
    Gomes LG; Huang N; Agrawal V; Mendonça BB; Bachega TA; Miller WL
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2913-6. PubMed ID: 18397975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Winkel CA; Casey ML; Worley RJ; Madden JD; MacDonald PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):104-7. PubMed ID: 6600168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt wasting in simple virilizing congenital adrenal hyperplasia.
    Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
    J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced need of glucocorticoid therapy in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency during pregnancy.
    Amadori P
    J Endocrinol Invest; 2006 Oct; 29(9):848-50. PubMed ID: 17114919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.